Skip to content Skip to footer
Subscribe Now

TOP 20

Diagnostics Companies Top 20 2021
Top 20 Diagnostics Companies Based on 2021 Revenue
The diagnostic companies continued to serve the high demand for diagnostic testing throughout the COVID-19 pandemic in 2021 Siemens Healthineers, Roche, GE Healthcare, and Abbott were the top players in the race for the global diagnostic companies PharmaShots has compiled a list of the top 20 diagnostics Companies based on their 2021 revenue in the…
June 9, 2022
Medical Device Companies Top 20 2021
Top 20 Medical Device Companies Based on 2021 Revenue
Despite the severe impact of the Covid-19 pandemic in 2020, the medical device market continued to emerge with patients' more significant needs and emerging diseases  In 2021, the medical device markets continued to supply personal protective equipment for the pandemic and new technological developments. Medtronic remains at the top of the ledger with total revenue…
May 12, 2022
BioPharma Companies Top 20 2021
Top 20 BioPharma Companies based on 2021 Total Revenue
While the COVID-19 pandemic has dominated the healthcare space for the last two years, some biopharma companies were involved in multiple deals, M&A, and the development of various drug candidates in other areas to diversify their portfolios While top Biopharma companies remain on the chart, however, in 2021, new players like Moderna, BioNTech, Viatris also…
April 14, 2022
Biopharma Deal Terminations Top 20 2021
Top 20 Biopharma Deal Terminations of 2021 Based on Total Deal Value
Shots: The biopharma industry saw numerous deal terminations in 2021. Clinical and regulatory results, change of control limitations, and strategic reprioritizations were among the most common reasons for deal termination. SOBI and Advent's acquisition agreement in 2021 ranked first under which Advent International offered to acquire SOBI. The second position goes to Galapagos’ development and…
March 10, 2022
Life Sciences Deals Top 20 2021
Top 20 Life Sciences Deals of 2021 by Total Deal Value
Shots: The life science industry saw high deal activity in 2021 staying in the range of an even busier 2020. Fourth-quarter 2021 set the tone with Recursion’s development and commercialization deal with Roche and Genentech for a total value of $12.7B, followed by Poseida Therapeutics’ development and commercialization deal with Takeda for $3.73B. This article is based on the 2021…
February 10, 2022
Biopharma M&A Top 20 2021
Top 20 Biopharma M&A of 2021 by Total Deal Value
Shots: Biopharma merger and acquisition activity continued under the radar with smaller deals through 2021. Despite the absence of eagerly-awaited mega-merger, there were a number of deals above $1 billion. CSL Limited holds the top rank by acquiring Vifor Pharma among the top 20 acquisitions with a total deal value of $11.7B. CSL adds  10…
January 20, 2022
Animal Health Companies Top 20 2020
TOP 20 Animal Health Companies of 2020 by Total Revenue
Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human life For a country’s economy and balanced human life, proper care and disease-free health of animals play a key role. Since rapid environmental change has targeted animal health, it becomes…
December 23, 2021
Prescription Drugs Based Top 20 2020
Top 20 Prescription Drugs Based on 2020 Revenue
Innovative horizons are broadening continuously in the field of medicines. Health is not only limited to physical well-being, it also reflects the mental status Pharmaceutical medicines are advancing rapidly in every area of requirement such as immunology, nephrology, oncology, neurology, and Medicines that focuses on treating disease and improving health We have compiled a list of global…
November 25, 2021
Generics Pharma Companies Top 20 2020
Top 20 Generics Pharma Companies Based On 2020 Revenue
Shots: Generic medicines are the backbone of the healthcare system and are identical to the innovator medicine in strength- effect- dosage form- and route of administration. These are allowed for sale after the patent expiry of the original drugs Our team at PharmaShots has compiled a list of the top 20 generic companies based on…
October 28, 2021
Oncology Companies Based Top 20 2020
Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue
Oncology is a rapidly evolving therapy area and all of the top Biopharma players are investing in the research and development of cancer therapies. In 2020- the world witnessed a major acquisition of Immunomedic by Gilead of $21B for Trodelvy Our team at PharmaShots has compiled a list of top 20 oncology companies based on…
September 9, 2021
Load more